首页 | 本学科首页   官方微博 | 高级检索  
检索        

骨髓间充质干细胞的肌源性诱导分化及转染VEGF基因的表达
引用本文:盛小刚,冯建章,吴书林,靳立军,余细勇,张斌.骨髓间充质干细胞的肌源性诱导分化及转染VEGF基因的表达[J].南方医科大学学报,2004,24(3):290-294.
作者姓名:盛小刚  冯建章  吴书林  靳立军  余细勇  张斌
作者单位:1. 广东省心血管病研究所心内科,广东,广州,510100
2. 广东省心血管病研究所中心实验室,广东,广州,510100
基金项目:国家自然科学基金项目(30271287)~~
摘    要:目的体外诱导兔骨髓间充质干细胞向肌源性细胞分化,并观察血管内皮生长因子AdTrackCMV-hVEGF165真核表达质粒转染骨髓间充质干细胞(mesenchymal stem cells, MSCs)后的表达。方法将20只兔随机分为对照组和实验组,从骨髓液中分离MSCs,对照组以低糖DMEM培养,实验组加用5-氮胞苷(10 mmol/L)诱导培养,第28天进行肌钙蛋白I免疫组化染色。另构建AdTrackCMV-hVEGF165真核表达质粒,通过脂质体转染对照组MSCs,用Northern blotting和Western blotting鉴定血管内皮生长因子(VEGF)的表达,并用ELISA法测定培养上清液中VEGF的浓度。结果成功分离培养出兔MSCs,实验组经5-氮胞苷诱导后MSCs向肌源性细胞分化,肌钙蛋白I免疫组化染色阳性。成功构建AdTrackCMV-hVEGF165真核表达质粒并通过脂质体转染MSCs,Northern blotting示转染的MSCs VEGF165表达信号明显强于未转染细胞,Western blotting 示转染VEGF165基因的MSC表达VEGF,ELISA法测定培养上清液中VEGF的浓度在转染后第3天(1 011 pg/ml)和第5天(1 027 pg/ml)达高峰,此后逐渐下降,但至第13天(349 pg/ml)仍显著高于空白对照(116 pg/ml)和pAdTrackCMV组(125 pg/ml),P<0.01。结论兔骨髓间充质干细胞可在体外向肌源性细胞分化,转染VEGF基因可表达VEGF,有望将干细胞移植和基因治

关 键 词:基因表达  动物  转基因/免疫学  骨髓间充质干细胞  肌源性细胞  血管内皮生长因子
文章编号:1000-2588(2004)03-0290-05
修稿时间:2003年9月8日

Differentiation of rabbit bone marrow mesenchymal stem cells into myogenic cells in vitro and expression of vascular endothelial growth factor gene after transfection
SHENG Xiao-gang,FENG Jian-zhang,WU Shulin,JIN Li-jun,YU Xi-yong,ZHANG Bin.Differentiation of rabbit bone marrow mesenchymal stem cells into myogenic cells in vitro and expression of vascular endothelial growth factor gene after transfection[J].Journal of Southern Medical University,2004,24(3):290-294.
Authors:SHENG Xiao-gang  FENG Jian-zhang  WU Shulin  JIN Li-jun  YU Xi-yong  ZHANG Bin
Institution:SHENG Xiao-gang1,FENG Jian-zhang1,WU Shulin1,JIN Li-jun1,YU Xi-yong2,ZHANG Bin1Department of Cardiology1,Research Center of Medical Science2,Guangdong Provincial Cardiovascular Institute,Guangzhou 510100,China
Abstract:Objective To induce the differentiation of rabbit bone marrow mesenchymal stem cells (MSCs) into myogenic cells in vitro, and to investigate the expression of vascular endothelial growth factor (VEGF) gene in AdTrackCMV-hVEGF165- transfected MSCs. Methods Twenty rabbits were divided equally into control group and experimental group, and MSCs were isolated and purified from their bone marrow by Percoll (1.073 g/ml) followed by cell culture in low-glucose DMEM supplemented with 10% fetal bovine serum. 5-azacytidine (5-Aza) was added into the cell culture of the experimental group on the third day. The expression of troponin I in MSCs was assayed by immunohistochemistry on the 28th day. AdTrackCMV- hVEGF165 eukaryotic expression vector was constructed and transfected into the MSCs, and subsequent VEGF expression was detected by Northern blotting and Western blotting while enzyme-linked immunosorbent assay (ILISA) was employed to examine the VEGF concentration in the supernatant of the culture medium. Results Following successful isolation and culture of the MSCs from rabbit bone marrow, 5-Aza-induced differentiation of the cells into myogenic cells was demonstrated by their positive staining for cardiac troponin I (cTnI). Northern blotting showed that the expression of VEGF 165 mRNA was much higher in the VEGF165 gene-transfected cells than in the control cells. Western blotting showed VEGF expression in the transfected cells. The concentration of VEGF in the supernatant mounted to the peak level 3-5 d after VEGF165 gene transfection (1 011-1 027 pg/ml) and decreased gradually thereafter, but still maintaining higher levels than those in the control group and pAdTrackCMV group (349 pg/ml vs 116 pg/ml and 125pg/ml, respectively, P<0.01) . Conclusion MSCs can be induced to differentiate into myogenic cells in vitro and express VEGF after VEGF gene transfection, and this success may provided a basis for combining MSC transplantation with gene therapy for regeneration of the damaged myocardial cells.
Keywords:gene expression  animals  gene transfer/immunology  mesenchymal stem cells  myogenic cells  vascular endothelial growth factor
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号